Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 26

1.

Bioluminescent, Nonlytic, Real-Time Cell Viability Assay and Use in Inhibitor Screening.

Duellman SJ, Zhou W, Meisenheimer P, Vidugiris G, Cali JJ, Gautam P, Wennerberg K, Vidugiriene J.

Assay Drug Dev Technol. 2015 Oct;13(8):456-65. doi: 10.1089/adt.2015.669. Epub 2015 Sep 18.

2.

The XTT cell proliferation assay applied to cell layers embedded in three-dimensional matrix.

Huyck L, Ampe C, Van Troys M.

Assay Drug Dev Technol. 2012 Aug;10(4):382-92. doi: 10.1089/adt.2011.391. Epub 2012 May 10.

3.

Exocytosis of MTT formazan could exacerbate cell injury.

Lü L, Zhang L, Wai MS, Yew DT, Xu J.

Toxicol In Vitro. 2012 Jun;26(4):636-44. doi: 10.1016/j.tiv.2012.02.006. Epub 2012 Feb 28.

PMID:
22401948
4.

A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution.

Auld DS, Zhang YQ, Southall NT, Rai G, Landsman M, MacLure J, Langevin D, Thomas CJ, Austin CP, Inglese J.

J Med Chem. 2009 Mar 12;52(5):1450-8. doi: 10.1021/jm8014525.

5.

A high density assay format for the detection of novel cytotoxic agents in large chemical libraries.

Shum D, Radu C, Kim E, Cajuste M, Shao Y, Seshan VE, Djaballah H.

J Enzyme Inhib Med Chem. 2008 Dec;23(6):931-45. doi: 10.1080/14756360701810082 .

6.

A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers.

Niles AL, Moravec RA, Eric Hesselberth P, Scurria MA, Daily WJ, Riss TL.

Anal Biochem. 2007 Jul 15;366(2):197-206. Epub 2007 Apr 12.

PMID:
17512890
7.

Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.

Berridge MV, Herst PM, Tan AS.

Biotechnol Annu Rev. 2005;11:127-52. Review.

PMID:
16216776
8.

A new multiplex assay allowing simultaneous detection of the inhibition of cell proliferation and induction of cell death.

Wesierska-Gadek J, Gueorguieva M, Ranftler C, Zerza-Schnitzhofer G.

J Cell Biochem. 2005 Sep 1;96(1):1-7.

PMID:
16052484
10.

Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay.

Ulukaya E, Colakogullari M, Wood EJ.

Chemotherapy. 2004 Apr;50(1):43-50.

PMID:
15084806
11.

The mitochondrial uncoupler dicumarol disrupts the MTT assay.

Collier AC, Pritsos CA.

Biochem Pharmacol. 2003 Jul 15;66(2):281-7.

PMID:
12826270
13.

Vitamin A as an enzyme that catalyzes the reduction of MTT to formazan by vitamin C.

Chakrabarti R, Kundu S, Kumar S, Chakrabarti R.

J Cell Biochem. 2000 Sep 18;80(1):133-8.

PMID:
11029760
15.

Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival.

Pagliacci MC, Spinozzi F, Migliorati G, Fumi G, Smacchia M, Grignani F, Riccardi C, Nicoletti I.

Eur J Cancer. 1993;29A(11):1573-7.

PMID:
8217365
17.

Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS.

Goodwin CJ, Holt SJ, Downes S, Marshall NJ.

J Immunol Methods. 1995 Feb 13;179(1):95-103.

PMID:
7868929
18.

Comparison of a novel redox dye cell growth assay to the ATP bioluminescence assay.

Squatrito RC, Connor JP, Buller RE.

Gynecol Oncol. 1995 Jul;58(1):101-5.

PMID:
7789873
19.

A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.

Marshall NJ, Goodwin CJ, Holt SJ.

Growth Regul. 1995 Jun;5(2):69-84. Review.

PMID:
7627094
20.

Supplemental Content

Support Center